Serum thyroglobulin concentrations predict disease-free remission and death in differentiated thyroid carcinoma

Clinical Endocrinology

Volumn 66, Issue 1, 2007, Pages 58-64

  Heemstra, Karen A ^a   Liu, Ying Y ^a   Stokkel, Marcel ^a   Kievit, Job ^a   Corssmit, Eleonora ^a   Pereira, Alberto M ^a   Romijn, Johannes A ^a   Smit, Johannes W A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

THYROGLOBULIN;

ADULT; ARTICLE; CLINICAL PROTOCOL; CONCENTRATION (PARAMETERS); DEATH; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROGNOSIS; REMISSION; ROC CURVE; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; TUMOR DIFFERENTIATION;

ADULT; AGED; AUTOANTIBODIES; CARCINOMA; COMBINED MODALITY THERAPY; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PROGNOSIS; RADIOPHARMACEUTICALS; THYROGLOBULIN; THYROID NEOPLASMS; THYROIDECTOMY; THYROTROPIN; TUMOR MARKERS, BIOLOGICAL;

EID: 33845622962     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2006.02685.x     Document Type: Article

References (27)

1. Hundahl, S.A., Fleming, I.D., Fremgen, A.M. & Menck, H.R. (1998) A National Cancer Data Base report on 53 856 cases of thyroid carcinoma treated in the US, 1985-1995. Cancer, 83, 2638-2648.
2. Eustatia-Rutten, C.F., Smit, J.W., Romijn, J.A., van der Kleij-Corssmit, E.P., Pereira, A.M., Stokkel, M.P. & Kievit, J. (2004) Diagnostic value of serum thyroglobulin measurements in the follow-up of differentiated thyroid carcinoma, a structured meta-analysis. Clinical Endocrinology, 61, 61-74.
3. Schlumberger, M., Pacini, F., Wiersinga, W.M., Toft, A., Smit, J.W., Sanchez, F.F., Lind, P., Limbert, E., Jarzab, B., Jamar, F., Duntas, L., Cohen, O. & Berg, G. (2004) Follow-up and management of differentiated thyroid carcinoma: a European perspective in clinical practice. European Journal of Endocrinology, 151, 539-548.
4. Ronga, G., Filesi, M., Ventroni, G., Vestri, A.R. & Signore, A. (1999) Value of the first serum thyroglobulin level after total thyroidectomy for the diagnosis of metastases from differentiated thyroid carcinoma. European Journal of Nuclear Medicine, 26, 1448-1452.
5. Hannequin, P., Liehn, J.C., Delisle, M.J., Deltour, G. & Valeyre, J. (1987) ROC analysis in radioimmunoassay: an application to the interpretation of thyroglobulin measurement in the follow-up of thyroid carcinoma. European Journal of Nuclear Medicine, 13, 203-206.
6. Giovanella, L., Ceriani, L. & Garancini, S. (2002) High-sensitive 2nd generation thyroglobulin immunoradiometric assay. Clinical application in differentiated thyroid cancer management. Quarterly Journal of Nuclear Medicine, 46, 319-322.
7. Lin, J.D., Huang, M.J., Hsu, B.R., Chao, T.C., Hsueh, C., Liu, F.H., Liou, M.J. & Weng, H.F. (2002) Significance of postoperative serum thyroglobulin levels in patients with papillary and follicular thyroid carcinomas. Journal of Surgical Oncology, 80, 45-51.
8. Baudin, E., Do, C.C., Cailleux, A.F., Leboulleux, S., Travagli, J.P. & Schlumberger, M. (2003) Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients. Journal of Clinical Endocrinology and Metabolism, 88, 1107-1111.
9. Cailleux, A.F., Baudin, E., Travagli, J.P., Ricard, M. & Schlumberger, M. (2000) Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer? Journal of Clinical Endocrinology and Metabolism, 85, 175-178.
10. Kloos, R.T. & Mazzaferri, E.L. (2005) A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later. Journal of Clinical Endocrinology and Metabolism, 90, 5047-5057.
11. Kim, T.Y., Kim, W.B., Kim, E.S., Ryu, J.S., Yeo, J.S., Kim, S.C., Hong, S.J. & Shong, Y.K. (2005) Serum thyroglobulin levels at the time of 131I remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients with differentiated thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 90, 1440-1445.
12. Menendez, T.E., Lopez Carballo, M.T., Rodriguez Erdozain, R.M., Forga, L.L., Goni Iriarte, M.J. & Barberia Layana, J.J. (2004) Prognostic value of thyroglobulin serum levels and 131I whole-body scan after initial treatment of low-risk differentiated thyroid cancer. Thyroid, 14, 301-306.
13. Wittekind, C. & Wagner, G. (1997) TNM Classification of Malignant Tumors, 5th edn. Springer, Berlin.
14. Morgenthaler, N.G., Froehlich, J., Rendl, J., Willnich, M., Alonso, C., Bergmann, A. & Reiners, C. (2002) Technical evaluation of a new immunoradiometric and a new immunoluminometric assay for thyroglobulin. Clinical Chemistry, 48, 1077-1083.
15. Mazzaferri, E.L., Robbins, R.J., Spencer, C.A., Braverman, L.E., Pacini, F., Wartofsky, L., Haugen, B.R., Sherman, S.I., Cooper, D.S., Braunstein, G.D., Lee, S., Davies, T.F., Arafah, B.M., Ladenson, P.W. & Pinchera, A. (2003) A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 88, 1433-1441.
16. Pacini, F., Molinaro, E., Lippi, F., Castagna, M.G., Agate, L., Ceccarelli, C., Taddei, D., Elisei, R., Capezzone, M. & Pinchera, A. (2001) Prediction of disease status by recombinant human TSH-stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 86, 5686-5690.
17. de Keizer, B., Koppeschaar, H.P., Zelissen, P.M., Lips, C.J., van Rijk, P.P., van Dijk, A. & de Klerk, J.M. (2001) Efficacy of high therapeutic doses of iodine-131 in patients with differentiated thyroid cancer and detectable serum thyroglobulin. European Journal of Nuclear Medicine, 28, 198-202.
18. Koh, J.M., Kim, E.S., Ryu, J.S., Hong, S.J., Kim, W.B. & Shong, Y.K. (2003) Effects of therapeutic doses of 131I in thyroid papillary carcinoma patients with elevated thyroglobulin level and negative 131I whole-body scan: comparative study. Clinical Endocrinology, 58, 421-427.
19. Pacini, F., Agate, L., Elisei, R., Capezzone, M., Ceccarelli, C., Lippi, F., Molinaro, E. & Pinchera, A. (2001) Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic (131)I whole body scan: comparison of patients treated with high (131)I activities versus untreated patients. Journal of Clinical Endocrinology and Metabolism, 86, 4092-4097.
20. Van Tol, K.M., Jager, P.L., de Vries, E.G., Piers, D.A., Boezen, H.M., Sluiter, W.J., Dullaart, R.P. & Links, T.P. (2003) Outcome in patients with differentiated thyroid cancer with negative diagnostic whole-body scanning and detectable stimulated thyroglobulin. European Journal of Endocrinology, 148, 589-596.
21. Spencer, C.A., Takeuchi, M. & Kazarosyan, M. (1996) Current status and performance goals for serum thyroglobulin assays. Clinical Chemistry, 42, 164-173.
22. Ligabue, A., Poggioli, M.C. & Zacchini, A. (1993) Interference of specific autoantibodies in the assessment of serum thyroglobulin. Journal of Nuclear Biology and Medicine, 37, 273-279.
23. Spencer, C.A., Takeuchi, M., Kazarosyan, M., Wang, C.C., Guttler, R.B., Singer, P.A., Fatemi, S., LoPresti, J.S. & Nicoloff, J.T. (1998) Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 83, 1121-1127.
24. Schaap, J., Eustatia-Rutten, C.F., Stokkel, M., Links, T.P., Diamant, M., van der Velde, E.A., Romijn, J.A. & Smit, J.W. (2002) Does radioiodine therapy have disadvantageous effects in non-iodine accumulating differentiated thyroid carcinoma? Clinical Endocrinology, 57, 117-124.
25. Ericsson, U.B., Christensen, S.B. & Thorell, J.I. (1985) A high prevalence of thyroglobulin autoantibodies in adults with and without thyroid disease as measured with a sensitive solid-phase immunosorbent radioassay. Clinical Immunology and Immunopathology, 37, 154-162.
26. Akamizu, T., Inoue, D., Kosugi, S., Kohn, L.D. & Mori, T. (1994) Further studies of amino acids (268-304) in thyrotropin (TSH)-lutropin/chorionic gonadotropin (LH/CG) receptor chimeras: cysteine-301 is important in TSH binding and receptor tertiary structure. Thyroid, 4, 43-48.
27. Baloch, Z., Carayon, P., Conte-Devolx, B., Demers, L.M., Feldt-Rasmussen, U., Henry, J.F., LiVosli, V.A., Niccoli-Sire, P., John, R., Ruf, J., Smyth, P.P., Spencer, C.A. & Stockigt, J.R. (2003) Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid, 13, 3-126.